Clinical Study
EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β-1a
Table 2
Mean values and paired changes from baseline in MSQOL-54 PCS and MCS and in EDSS scores.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MCS and PCS are expressed on a scale of 0 (poorest quality of life) to 100 (best possible quality of life). Paired changes from baseline to 24 months and ET in MSQOL-54 PCS and MCS and EDSS scores were also previously reported in Moore et al. [6]. numbers lower than 196 (number of patients who completed the 24-month study); data for these endpoints were not available for all patients who completed the study. value calculated using a two-sided Wilcoxon matched pairs signed-rank test. EDSS, Expanded Disability Status Scale; ET, early termination; MCS, mental health composite score; MSQOL-54, Multiple Sclerosis Quality of Life-54; NS, not statistically significant; PCS, physical health composite score; SD, standard deviation. |